Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis

Citation:

Elefsiniotis LS, Dalekos GN, Koskinas J, Ioannidou P, Cholongitas E, Manolakopoulos S, Goulis J, Vlachogiannakos J, Deutsch M, Triantos CK, et al. Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis. In: HEPATOLOGY. Vol. 64. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 990A–991A. Copy at http://www.tinyurl.com/yqjvc6f3